Monday, January 04, 2010 6:44:45 PM
Most probably this possible new spin-off company will start on OTCBB with some starting PPS somewhere 1-2$ and prior RS 1:10.In any case whatever will happen it's dificult to estimate what and how PPS will react in mid-term.AS for all dev stage companies with no history of revenues and so on .
But pure hypotetical scenario might look like this:
If on 1/22 Fampridine is finnaly approved and we have a new spin-off
company integrated into former CAML we should take into account
that AS/OS ( 2:1 ) is prety unflavourable.Usualy is 5:1 or higher to make a "room" so RS of 1:10 for me it seems reasonable.
After that we'll 5M OS with float of some 600K.
Any possibilities to gauge what will be the open price is
mission impossible as the only information on hand at that time will be future projected revenues.
But let's say if those future revenues are estimated at 5M $
( don't forget we're talking about broad market and prospectable drug product ) then future PPS should be some 3$.
As all we know MM's behaviour on such openings and very thin float
in game everything might happen.
We might see 2,5 or 10$ on first day close.Everything is possible.
So if you have 100K shs on hand and tomorow sell them on 0.05 you'll have 5k $ in your pocket.
If you wait and if scenario will work out.
You have 10K shares after RS and sell them for 2,5,10 $, so
there is 20,50,100 K $ in your pocket.
So the difference is pretty obviously.
Everything is PURE HYPOTHETICAL !, but when playing with shells everything is possible and damn I'm waiting for this CAML monster to wake up for some 4 years now.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM